Omicron-Targeting Boosters From Moderna, Pfizer Ready for US Use

Sept. 1, 2022, 11:22 PM UTC

Covid booster shots that target the most common new variants of the virus should become available in the US within days, after the Centers for Disease Control and Prevention signed off on the rollout of updated vaccines Thursday.

CDC Director Rochelle Walensky endorsed the use of the new shots after, in two 13-1 votes, outside vaccine and health experts gave their backing to the booster shots from Moderna Inc. and from Pfizer Inc. and BioNTech SE.

“This recommendation followed a comprehensive scientific evaluation and robust scientific discussion. If you are eligible, there is no bad time to get your ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.